Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors
Clinical trial NCT01286896 · COMPLETED
Trial details
- NCT number
- NCT01286896
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-11
- Primary completion
- 2011-12-27
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.